<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/mostaccessed?quantity=&amp;format=rss&amp;version=">
        <title>BioMed Central - Most accessed articles</title>
        <link>http://www.biomedcentral.com/</link>
        <description>The most accessed research articles published by BioMed Central</description>
        <dc:date>2010-01-22T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.nutritionj.com/content/4/1/24" />
                                <rdf:li rdf:resource="http://www.ojrd.com/content/3/1/15" />
                                <rdf:li rdf:resource="http://www.nutritionj.com/content/9/1/3" />
                                <rdf:li rdf:resource="http://genomebiology.com/2010/11/1/R7" />
                                <rdf:li rdf:resource="http://ccforum.com/content/8/4/R204" />
                                <rdf:li rdf:resource="http://www.ijbnpa.org/content/1/1/3" />
                                <rdf:li rdf:resource="http://ccforum.com/content/14/1/R1" />
                                <rdf:li rdf:resource="http://www.trialsjournal.com/content/11/1/2" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2148/10/15" />
                                <rdf:li rdf:resource="http://www.hqlo.com/content/1/1/29" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.nutritionj.com/content/4/1/24">
        <title>Childhood obesity, prevalence and prevention</title>
        <description>Childhood obesity has reached epidemic levels in developed countries. Twenty five percent of children in the US are overweight and 11% are obese. Overweight and obesity in childhood are known to have significant impact on both physical and psychological health. The mechanism of obesity development is not fully understood and it is believed to be a disorder with multiple causes. Environmental factors, lifestyle preferences, and cultural environment play pivotal roles in the rising prevalence of obesity worldwide. In general, overweight and obesity are assumed to be the results of an increase in caloric and fat intake. On the other hand, there are supporting evidence that excessive sugar intake by soft drink, increased portion size, and steady decline in physical activity have been playing major roles in the rising rates of obesity all around the world. Consequently, both over-consumption of calories and reduced physical activity are involved in childhood obesity.Almost all researchers agree that prevention could be the key strategy for controlling the current epidemic of obesity. Prevention may include primary prevention of overweight or obesity, secondary prevention or prevention of weight regains following weight loss, and avoidance of more weight increase in obese persons unable to lose weight. Until now, most approaches have focused on changing the behaviour of individuals in diet and exercise. It seems, however, that these strategies have had little impact on the growing increase of the obesity epidemic. While about 50% of the adults are overweight and obese in many countries, it is difficult to reduce excessive weight once it becomes established. Children should therefore be considered the priority population for intervention strategies. Prevention may be achieved through a variety of interventions targeting built environment, physical activity, and diet. Some of these potential strategies for intervention in children can be implemented by targeting preschool institutions, schools or after-school care services as natural setting for influencing the diet and physical activity. All in all, there is an urgent need to initiate prevention and treatment of obesity in children.</description>
        <link>http://www.nutritionj.com/content/4/1/24</link>
                <dc:creator>Mahshid Dehghan</dc:creator>
                <dc:creator>Noori Akhtar-Danesh</dc:creator>
                <dc:creator>Anwar Merchant</dc:creator>
                <dc:source>Nutrition Journal 2005, 4:24</dc:source>
        <dc:date>2005-09-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2891-4-24</dc:identifier>
        <prism:publicationName>Nutrition Journal</prism:publicationName>
        <prism:issn>1475-2891</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2005-09-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ojrd.com/content/3/1/15">
        <title>Brachydactyly</title>
        <description>Brachydactyly (&quot;short digits&quot;) is a general term that refers to disproportionately short fingers and toes, and forms part of the group of limb malformations characterized by bone dysostosis. The various types of isolated brachydactyly are rare, except for types A3 and D. Brachydactyly can occur either as an isolated malformation or as a part of a complex malformation syndrome. To date, many different forms of brachydactyly have been identified. Some forms also result in short stature. In isolated brachydactyly, subtle changes elsewhere may be present. Brachydactyly may also be accompanied by other hand malformations, such as syndactyly, polydactyly, reduction defects, or symphalangism.For the majority of isolated brachydactylies and some syndromic forms of brachydactyly, the causative gene defect has been identified. In isolated brachydactyly, the inheritance is mostly autosomal dominant with variable expressivity and penetrtance.Diagnosis is clinical, anthropometric and radiological. Prenatal diagnosis is usually not indicated for isolated forms of brachydactyly, but may be appropriate in syndromic forms. Molecular studies of chorionic villus samples at 11 weeks of gestation and by amniocentesis after the 14th week of gestation can provide antenatal diagnosis if the causative mutation in the family is known. The nature of genetic counseling depends both on the pattern of inheritance of the type of brachydactyly present in the family and on the presence or absence of accompanying symptoms.There is no specific management or treatment that is applicable to all forms of brachydactyly. Plastic surgery is only indicated if the brachydactyly affects hand function or for cosmetic reasons, but is typically not needed. Physical therapy and ergotherapy may ameliorate hand function. Prognosis for the brachydactylies is strongly dependent on the nature of the brachydactyly, and may vary from excellent to severely influencing hand function. If brachydactyly forms part of a syndromic entity, prognosis often depends on the nature of the associated anomalies.</description>
        <link>http://www.ojrd.com/content/3/1/15</link>
                <dc:creator>Samia Temtamy</dc:creator>
                <dc:creator>Mona Aglan</dc:creator>
                <dc:source>Orphanet Journal of Rare Diseases 2008, 3:15</dc:source>
        <dc:date>2008-06-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1172-3-15</dc:identifier>
        <prism:publicationName>Orphanet Journal of Rare Diseases</prism:publicationName>
        <prism:issn>1750-1172</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2008-06-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionj.com/content/9/1/3">
        <title>The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide</title>
        <description>Background:
A plant-based diet protects against chronic oxidative stress-related diseases. Dietary plants contain variable chemical families and amounts of antioxidants. It has been hypothesized that plant antioxidants may contribute to the beneficial health effects of dietary plants. Our objective was to develop a comprehensive food database consisting of the total antioxidant content of typical foods as well as other dietary items such as traditional medicine plants, herbs and spices and dietary supplements. This database is intended for use in a wide range of nutritional research, from in vitro and cell and animal studies, to clinical trials and nutritional epidemiological studies.
Methods:
We procured samples from countries worldwide and assayed the samples for their total antioxidant content using a modified version of the FRAP assay. Results and sample information (such as country of origin, product and/or brand name) were registered for each individual food sample and constitute the Antioxidant Food Table.
Results:
The results demonstrate that there are several thousand-fold differences in antioxidant content of foods. Spices, herbs and supplements include the most antioxidant rich products in our study, some exceptionally high. Berries, fruits, nuts, chocolate, vegetables and products thereof constitute common foods and beverages with high antioxidant values.
Conclusions:
This database is to our best knowledge the most comprehensive Antioxidant Food Database published and it shows that plant-based foods introduce significantly more antioxidants into human diet than non-plant foods. Because of the large variations observed between otherwise comparable food samples the study emphasizes the importance of using a comprehensive database combined with a detailed system for food registration in clinical and epidemiological studies. The present antioxidant database is therefore an essential research tool to further elucidate the potential health effects of phytochemical antioxidants in diet.</description>
        <link>http://www.nutritionj.com/content/9/1/3</link>
                <dc:creator>Monica Carlsen</dc:creator>
                <dc:creator>Bente Halvorsen</dc:creator>
                <dc:creator>Kari Holte</dc:creator>
                <dc:creator>Siv Bohn</dc:creator>
                <dc:creator>Steinar Dragland</dc:creator>
                <dc:creator>Laura Sampson</dc:creator>
                <dc:creator>Carol Willey</dc:creator>
                <dc:creator>Haruki Senoo</dc:creator>
                <dc:creator>Yuko Umezono</dc:creator>
                <dc:creator>Chiho Sanada</dc:creator>
                <dc:creator>Ingrid Barikmo</dc:creator>
                <dc:creator>Nega Berhe</dc:creator>
                <dc:creator>Walter Willett</dc:creator>
                <dc:creator>Katherine Phillips</dc:creator>
                <dc:creator>David Jacobs</dc:creator>
                <dc:creator>Rune Blomhoff</dc:creator>
                <dc:source>Nutrition Journal 2010, 9:3</dc:source>
        <dc:date>2010-01-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2891-9-3</dc:identifier>
        <prism:publicationName>Nutrition Journal</prism:publicationName>
        <prism:issn>1475-2891</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-01-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://genomebiology.com/2010/11/1/R7">
        <title>Genome-wide prediction of transcription factor binding sites using an integrated model </title>
        <description>We present an integrated method called Chromia for the genome-wide identification of functional target loci of transcription factors. Designed to capture the characteristic patterns of a transcription factor binding motif occurrences and the histone profiles associated with regulatory elements such as promoters and enhancers, Chromia significantly outperforms other methods in the identification of 13 transcription factor binding sites in mouse embryonic stem cells, evaluated by both binding (ChIP-seq) and functional (RNAi knockdown) experiments.</description>
        <link>http://genomebiology.com/2010/11/1/R7</link>
                <dc:creator>Kyoung-Jae Won</dc:creator>
                <dc:creator>Bing Ren</dc:creator>
                <dc:creator>Wei Wang</dc:creator>
                <dc:source>Genome Biology 2010, 11:R7</dc:source>
        <dc:date>2010-01-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/gb-2010-11-1-r7</dc:identifier>
        <prism:publicationName>Genome Biology</prism:publicationName>
        <prism:issn>1465-6906</prism:issn>
        <prism:volume>11</prism:volume>
        <prism:startingPage>R7</prism:startingPage>
        <prism:publicationDate>2010-01-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://ccforum.com/content/8/4/R204">
        <title>Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group</title>
        <description>IntroductionThere is no consensus definition of acute renal failure (ARF) in critically ill patients. More than 30 different definitions have been used in the literature, creating much confusion and making comparisons difficult. Similarly, strong debate exists on the validity and clinical relevance of animal models of ARF; on choices of fluid management and of end-points for trials of new interventions in this field; and on how information technology can be used to assist this process. Accordingly, we sought to review the available evidence, make recommendations and delineate key questions for future studies.
Methods:
We undertook a systematic review of the literature using Medline and PubMed searches. We determined a list of key questions and convened a 2-day consensus conference to develop summary statements via a series of alternating breakout and plenary sessions. In these sessions, we identified supporting evidence and generated recommendations and/or directions for future research.
Results:
We found sufficient consensus on 47 questions to allow the development of recommendations. Importantly, we were able to develop a consensus definition for ARF. In some cases it was also possible to issue useful consensus recommendations for future investigations. We present a summary of the findings. (Full versions of the six workgroups&apos; findings are available on the internet at http://www.ADQI.net)
Conclusion:
Despite limited data, broad areas of consensus exist for the physiological and clinical principles needed to guide the development of consensus recommendations for defining ARF, selection of animal models, methods of monitoring fluid therapy, choice of physiological and clinical end-points for trials, and the possible role of information technology.</description>
        <link>http://ccforum.com/content/8/4/R204</link>
                <dc:creator>Rinaldo Bellomo</dc:creator>
                <dc:creator>Claudio Ronco</dc:creator>
                <dc:creator>John Kellum</dc:creator>
                <dc:creator>Ravindra Mehta</dc:creator>
                <dc:creator>Paul Palevski</dc:creator>
                <dc:source>Critical Care 2004, 8:R204</dc:source>
        <dc:date>2004-05-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/cc2872</dc:identifier>
        <prism:publicationName>Critical Care</prism:publicationName>
        <prism:issn>1364-8535</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>R204</prism:startingPage>
        <prism:publicationDate>2004-05-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ijbnpa.org/content/1/1/3">
        <title>Food Advertising and Marketing Directed at Children and Adolescents in the US</title>
        <description>In recent years, the food and beverage industry in the US has viewed children and adolescents as a major market force. As a result, children and adolescents are now the target of intense and specialized food marketing and advertising efforts. Food marketers are interested in youth as consumers because of their spending power, their purchasing influence, and as future adult consumers. Multiple techniques and channels are used to reach youth, beginning when they are toddlers, to foster brand-building and influence food product purchase behavior. These food marketing channels include television advertising, in-school marketing, product placements, kids clubs, the Internet, toys and products with brand logos, and youth-targeted promotions, such as cross-selling and tie-ins. Foods marketed to children are predominantly high in sugar and fat, and as such are inconsistent with national dietary recommendations. The purpose of this article is to examine the food advertising and marketing channels used to target children and adolescents in the US, the impact of food advertising on eating behavior, and current regulation and policies.</description>
        <link>http://www.ijbnpa.org/content/1/1/3</link>
                <dc:creator>Mary Story</dc:creator>
                <dc:creator>Simone French</dc:creator>
                <dc:source>International Journal of Behavioral Nutrition and Physical Activity 2004, 1:3</dc:source>
        <dc:date>2004-02-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1479-5868-1-3</dc:identifier>
        <prism:publicationName>International Journal of Behavioral Nutrition and Physical Activity</prism:publicationName>
        <prism:issn>1479-5868</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2004-02-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://ccforum.com/content/14/1/R1">
        <title>Ventilation with lower tidal volumes as compared to conventional tidal volumes for patients without acute lung injury - a preventive randomized controlled trial</title>
        <description>IntroductionRecent cohort studies have identified the use of large tidal volumes as a major risk factor for development of lung injury in mechanically ventilated patients without acute lung injury (ALI). We compared the effect of conventional with lower tidal volumes on pulmonary inflammation and development of lung injury in critically ill patients without ALI at the onset of mechanical ventilation.
Methods:
We performed a randomized controlled nonblinded preventive trial comparing mechanical ventilation with tidal volumes of 10 ml versus 6 ml per kilogram of predicted body weight in critically ill patients without ALI at the onset of mechanical ventilation. The primary end point was cytokine levels in bronchoalveolar lavage fluid and plasma during mechanical ventilation. The secondary end point was the development of lung injury, as determined by consensus criteria for ALI, duration of mechanical ventilation, and mortality.
Results:
One hundred fifty patients (74 conventional versus 76 lower tidal volume) were enrolled and analyzed. No differences were observed in lavage fluid cytokine levels at baseline between the randomization groups. Plasma interleukin-6 (IL-6) levels decreased significantly more strongly in the lower-tidal-volume group ((from 51 (20 to 182) ng/ml to 11 (5 to 20) ng/ml versus 50 (21 to 122) ng/ml to 21 (20 to 77) ng/ml; P = 0.01)). The trial was stopped prematurely for safety reasons because the development of lung injury was higher in the conventional tidal-volume group as compared with the lower tidal-volume group (13.5% versus 2.6%; P = 0.01). Univariate analysis showed statistical relations between baseline lung-injury score, randomization group, level of positive end-expiratory pressure (PEEP), the number of transfused blood products, the presence of a risk factor for ALI, and baseline IL-6 lavage fluid levels and the development of lung injury. Multivariate analysis revealed the randomization group and the level of PEEP as independent predictors of the development of lung injury.
Conclusions:
Mechanical ventilation with conventional tidal volumes is associated with sustained cytokine production, as measured in plasma. Our data suggest that mechanical ventilation with conventional tidal volumes contributes to the development of lung injury in patients without ALI at the onset of mechanical ventilation.Trial registrationISRCTN82533884</description>
        <link>http://ccforum.com/content/14/1/R1</link>
                <dc:creator>Rogier Determann</dc:creator>
                <dc:creator>Annick Royakkers</dc:creator>
                <dc:creator>Esther Wolthuis</dc:creator>
                <dc:creator>Alexander Vlaar</dc:creator>
                <dc:creator>Goda Choi</dc:creator>
                <dc:creator>Frederique Paulus</dc:creator>
                <dc:creator>Jorrit-Jan Hofstra</dc:creator>
                <dc:creator>Mart de Graaff</dc:creator>
                <dc:creator>Johanna Korevaar</dc:creator>
                <dc:creator>Marcus Schultz</dc:creator>
                <dc:source>Critical Care 2010, 14:R1</dc:source>
        <dc:date>2010-01-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/cc8230</dc:identifier>
        <prism:publicationName>Critical Care</prism:publicationName>
        <prism:issn>1364-8535</prism:issn>
        <prism:volume>14</prism:volume>
        <prism:startingPage>R1</prism:startingPage>
        <prism:publicationDate>2010-01-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.trialsjournal.com/content/11/1/2">
        <title>Questionnaires in clinical trials: guidelines for optimal design and administration</title>
        <description>A good questionnaire design for a clinical trial will minimise bias and maximise precision in the estimates of treatment effect within budget. Attempts to collect more data than will be analysed may risk reducing recruitment (reducing power) and increasing losses to follow-up (possibly introducing bias). The mode of administration can also impact on the cost, quality and completeness of data collected. There is good evidence for design features that improve data completeness but further research is required to evaluate strategies in clinical trials. Theory-based guidelines for style, appearance, and layout of self-administered questionnaires have been proposed but require evaluation.</description>
        <link>http://www.trialsjournal.com/content/11/1/2</link>
                <dc:creator>Phil Edwards</dc:creator>
                <dc:source>Trials 2010, 11:2</dc:source>
        <dc:date>2010-01-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-6215-11-2</dc:identifier>
        <prism:publicationName>Trials</prism:publicationName>
        <prism:issn>1745-6215</prism:issn>
        <prism:volume>11</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2010-01-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2148/10/15">
        <title>The ADH1B Arg47His polymorphism in East Asian populations and expansion of rice domestication in history</title>
        <description>Background:
The emergence of agriculture about 10,000 years ago marks a dramatic change in human evolutionary history. The diet shift in agriculture societies might have a great impact on the genetic makeup of Neolithic human populations. The regionally restricted enrichment of the class I alcohol dehydrogenase sequence polymorphism (ADH1BArg47His) in southern China and the adjacent areas suggests Darwinian positive selection on this genetic locus during Neolithic time though the driving force is yet to be disclosed.
Results:
We studied a total of 38 populations (2,275 individuals) including Han Chinese, Tibetan and other ethnic populations across China. The geographic distribution of the ADH1B*47His allele in these populations indicates a clear east-to-west cline, and it is dominant in south-eastern populations but rare in Tibetan populations. The molecular dating suggests that the emergence of the ADH1B*47His allele occurred about 10,000~7,000 years ago.
Conclusion:
We present genetic evidence of selection on the ADH1BArg47His polymorphism caused by the emergence and expansion of rice domestication in East Asia. The geographic distribution of the ADH1B*47His allele in East Asia is consistent with the unearthed culture relic sites of rice domestication in China. The estimated origin time of ADH1B*47His allele in those populations coincides with the time of origin and expansion of Neolithic agriculture in southern China.</description>
        <link>http://www.biomedcentral.com/1471-2148/10/15</link>
                <dc:creator>Yi Peng</dc:creator>
                <dc:creator>Hong Shi</dc:creator>
                <dc:creator>Xue-bin Qi</dc:creator>
                <dc:creator>Chun-jie Xiao</dc:creator>
                <dc:creator>Hua Zhong</dc:creator>
                <dc:creator>Run-lin Ma</dc:creator>
                <dc:creator>Bing Su</dc:creator>
                <dc:source>BMC Evolutionary Biology 2010, 10:15</dc:source>
        <dc:date>2010-01-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2148-10-15</dc:identifier>
        <prism:publicationName>BMC Evolutionary Biology</prism:publicationName>
        <prism:issn>1471-2148</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2010-01-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.hqlo.com/content/1/1/29">
        <title>The Hospital Anxiety And Depression Scale</title>
        <description>There is a need to assess the contribution of mood disorder, especially anxiety and depression, in order to understand the experience of suffering in the setting of medical practice.Most physicians are aware of this aspect of the illness of their patients but many feel incompetent to provide the patient with reliable information. The Hospital Anxiety And Depression Scale, or HADS, was designed to provide a simple yet reliable tool for use in medical practice. The term &apos;hospital&apos; in its title suggests that it is only valid in such a setting but many studies conducted throughout the world have confirmed that it is valid when used in community settings and primary care medical practice.It should be emphasised that self-assessment scales are only valid for screening purposes; definitive diagnosis must rest on the process of clinical examination.</description>
        <link>http://www.hqlo.com/content/1/1/29</link>
                <dc:creator>Richard Snaith</dc:creator>
                <dc:source>Health and Quality of Life Outcomes 2003, 1:29</dc:source>
        <dc:date>2003-08-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7525-1-29</dc:identifier>
        <prism:publicationName>Health and Quality of Life Outcomes</prism:publicationName>
        <prism:issn>1477-7525</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>29</prism:startingPage>
        <prism:publicationDate>2003-08-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
